SGLT2 INHIBITORS: A NEW CLASS OF DRUGS FOR TYPE-II DIABETES MELLITUS
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 10
Abstract
Diabetes is on the rise. No longer a disease of predominantly rich nations, the prevalence of diabetes is steadily increasing everywhere, most markedly in the world’s middle-income countries. Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a new group of oral medications used for treating type II Diabetes Mellitus. The drugs work by helping the kidneys to lower the blood glucose levels. Globally, an estimated 422 million adults were living with diabetes in 2014, compared to 108 million in 1980. The global prevalence of diabetes has nearly doubled since 1980, rising from 4.7% to 8.5% in the adult population. This reflects an increase in associated risk factors such as being overweight or obese. Over the past decade, diabetes prevalence has risen faster in low- and middle-income countries than in high-income countries. The present therapeutic classes of anti-diabetic drugs are not adequately effective in maintaining long-term glycemic control in the most patients. Sodium glucose transporter-2 (SGLT2) inhibitors including Dapagliflozin, Canagliflozin and Empagliflozin act by a novel insulin-independent mechanism by blocking glucose reabsorption in the proximal convoluted tubule resulting in markedly increased glycosuria, and blocking the formation of proteins.
Authors and Affiliations
Lahari Samudrala
Keywords
Related Articles
- EP ID EP618988
- DOI -
- Views 168
- Downloads 0
THREE NEW UNREPORTED BASIDIOMYCOTA MACROFUNGI FROM JAMMU AND KASHMIR, INDIA
The present paper discusses the study of systematic survey for the exploration of agarics from North Kashmir. The area exhibits varied climatic and topographic conditions and provide an environment for the lavish growth...
ANTIMICROBIAL PROPERTIES OF THE SEED EXTRACT AND FRACTIONS OF PICRALIMA NITIDA (STAPF) T. DURAND AND H. DURAND
The study investigated the antimicrobial property of the seed extract and its fractions on some typed and clinical isolates of bacteria and fungi. The powdered seed was macerated in 50% ethanol and screened for various p...
ROLE OF METFORMIN AND L-ARGININE COMBINATION IN SICKLE CELL DISEASE PAINS: A PILOT LABORATORY AND CLINICAL STUDY, AND MINI-REVIEW.
Sickle cell disease (SCD) is an inherited disorder of haemoglobin which is frequent in areas of high malaria transmission. Deoxygenation-induced hemoglobin polymerization in SCD is the stimulus for the excessive inflamma...
BIOCHEMICAL STUDIES ON GALECTIN-3 AS FIBROTIC MARKER IN HEPATITIS C PATIENTS
Although it is the gold standard for assessing hepatitis C virus (HCV)-related fibrosis, Liver biopsy is invasive and prone to complications. This study was designed to study non-invasive methods for the assessment of li...
LIPID PEROXIDATION, ANTIOXIDANT PROFILE AND SOME BIOCHEMICAL PARAMETERS IN RAT APPLIED AMINOGLYCOZIDE
Amikacin were used for the treatment of infections caused by Gram (-) bacteria, have serious nephrotoxic and ototoxic side-effects. Effects of the amikacin administrated at therapeutic doses on blood lipid peroxidation,...